$16.51
Price
$851M
Market Cap
7.4
P/E Ratio
13.2
Forward P/E
$2.23
EPS (TTM)
—
Dividend Yield
$395M
Cash
$43M
Total Debt
52M
Shares Out
$8.40
$21.03
52-Week Range
Institutional Ownership of THERAVANCE BIOPHARMA INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for THERAVANCE BIOPHARMA INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2022-Q3 | |||||
| SELL | EXIT | — | — | $9.34 | |
| 2022-Q2 | |||||
| SELL | -6.3% | 28.1M | $26M | $9.10 | |
Insider Trading for THERAVANCE BIOPHARMA INC
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.